Sarah Brady
Women's Health · Cookeville, TNNPI 1013293463
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.0% of the total across 117 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 22.6% — the pattern of someone who eats at a lot of different presentations.
Across 117 payments — averaging $19.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$522
- Sumitomo Pharma America, Inc.$471
- AbbVie$373
- Pfizer$223
- Exeltis, USA Inc.$122
- Therapeuticsmd, Inc.$89
- plus $516 from 15 others
What the payments were for
- Food & beverage$2,13192%
- Education$1858%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 20 | $522 |
| Sumitomo Pharma America, Inc. | 26 | $471 |
| AbbVie(2 entities) | 18 | $373 |
| Pfizer | 14 | $223 |
| Exeltis, USA Inc. | 7 | $122 |
| Therapeuticsmd, Inc. | 6 | $89 |
| Medtronic | 1 | $81 |
| Mylan Pharmaceuticals Inc. | 6 | $78 |
| Coloplast | 1 | $48 |
| Boston Scientific | 2 | $44 |
| Baxter Healthcare | 2 | $42 |
| Mayne Pharma Commercial LLC | 3 | $40 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| Organon | 2 | $30 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Olympus America Inc. | 1 | $19 |
| Urovant Sciences Inc | 1 | $19 |
| Bayer | 1 | $17 |
| Exact Sciences | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Myovant Sciences Inc. | 1 | $14 |
How this compares
$2,316 in reported general payments places this provider in the 80th percentile of 202 women's health providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 41 | $27,816 |
| GemtesaVibegron | 34 | $24,589 |
| Estradiol | 209 | $12,290 |
| PremarinEstrogens, Conjugated | 29 | $11,592 |
| Clobetasol Propionate | 37 | $2,076 |
| Trospium Chloride | 21 | $1,389 |
| Solifenacin Succinate | 14 | $1,371 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 120 | $1,366 |
| ProgesteroneProgesterone, Micronized | 71 | $1,243 |
| NitrofurantoinNitrofurantoin Macrocrystal | 33 | $1,171 |
| Methenamine Hippurate | 12 | $925 |
| DottiEstradiol | 13 | $915 |
| Fluconazole | 39 | $245 |
| Amitriptyline Hcl | 25 | $164 |
| Cephalexin | 22 | $137 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $522 | $27,81641 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $471 | $24,58934 claims |
| PfizerPremarin | $223 | $11,59229 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 202 women's health providers in Tennessee.
Other women's health in Cookeville
- Haley WoodFranklin$92K
- Dana DemossNashville$76K
- Royanne MooreNashville$29K
- Laurie TompkinsBrentwood$27K
- Lana HirschNashville$24K
- Yoshie DarnallNashville$10K
- Lisa GoehringNashville$9K
- Anya ZerillaKnoxville$8K
- Catherine KingeryKnoxville$7K
- Lindsey BakshNashville$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.